Study of acute respiratory distress syndrome: features and outcomes
Part of Lungs & breathing clinical trials.
This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are on one of these types of breathing support: high-flow oxygen (at least 30 L/min), a pressure mask (noninvasive ventilation), or a breathing tube (mechanical ventilation).
- Your oxygen level in the blood is low compared to the amount of extra oxygen you are getting (PaO2/FiO2 ≤ 300).
- A chest X-ray or CT scan shows cloudy areas (opacities) in both lungs that are not fully explained by other causes like fluid or collapsed lung.
- Your breathing failure is not due to heart failure or too much fluid in the body.
- You are not on long-term oxygen or a home breathing machine (except for sleep apnea), and you are not expected to need breathing support for less than 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study tests two types of breathing support—CPAP (a mask that pushes air into your lungs) and high-flow nasal oxygen (a special tube in your nose)—to see which works better for people with ARDS, a serious lung condition. It may help you breathe more easily without needing a breathing tube.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.